Quantinno Capital Management’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
Quantinno Capital Management's CAPR Position: Q3 2026 in Review
Quantinno Capital Management increased its Capricor Therapeutics (CAPR) stake by 1,573% in Q3 2026, buying an estimated $2.59M and bringing the position to 248,285 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2057.
Quantinno Capital Management first reported a position in CAPR in Q4 2025 and has held it in 4 quarters since. 158 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.
- Quantinno Capital Management held 248,285 shares of Capricor Therapeutics worth $2.35M as of Q3 2026.
- Quantinno Capital Management bought 233,444 Capricor Therapeutics shares in Q3 2026, an estimated $2.59M.
- Capricor Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2057 holding.
- Quantinno Capital Management first reported a position in Capricor Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 158 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.